|

Rivaroxaban 10 MG Clinical Trials

2 actively recruiting trials

Also known as: Placebo, Xarelto

Pipeline

Phase 3: 1Phase 2/3: 1

Top Sponsors

  • Ottawa Hospital Research Institute2

Indications

  • Venous Thromboembolism2
  • Cancer2
  • Urologic Cancer1

Other2 trials

Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters
Phase 3
VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.